Zobrazeno 1 - 10 of 42 pro vyhledávání: '"J H, Ficker"'
4
Metastasiertes Lungenkarzinom – therapierbare molekulare Alterationen
Autor: W. M. Brückl, J. H. Ficker
Publikováno v: Der Pneumologe. 16:343-352
In den letzten Jahren haben sich die Uberlebenschancen fur Patienten mit metastasierten nichtkleinzelligen Lungenkarzinomen („non-small cell lung carcinoma“, NSCLC) drastisch verbessert. Das liegt v. a. an der Einfuhrung der Immuntherapie/Immunch
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8774ace7dac0fee236cb54665763fe78
https://doi.org/10.1007/s10405-019-0264-4
Zobrazit plný text záznamu
6
Der schwere lebensbedrohliche Asthmaanfall
Autor: G.-S. Haarmeyer, J. H. Ficker, D. Muschner
Publikováno v: Der Pneumologe. 15:174-182
Schwere lebensbedrohliche Asthmaexazerbationen sind eine besondere Herausforderung fur die praklinische und intensivmedizinische Versorgung. Risikoindikatoren fur einen schweren lebensbedrohlichen Asthmaanfall sind u. a. zuruckliegende schwere („ne
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::034ec037f4ac6fa4d16fab4c1c38042b
https://doi.org/10.1007/s10405-018-0171-0
Zobrazit plný text záznamu
7
[Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids]
Autor: J H, Ficker, W M, Brückl
Publikováno v: Pneumologie (Stuttgart, Germany). 73(7)
Dyspnea is a leading symptom in COPD. Bronchodilators (long acting anticholinergics and long acting beta agonists) are the mainstay of medical treatment. Non pharmacological therapies like pulmonary rehabilitation, long-term oxygen therapy or lung vo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0925ebad70b9556121942f2c023b198c
https://pubmed.ncbi.nlm.nih.gov/31291670
Zobrazit plný text záznamu
8
[Rebiopsy for Patients with Lung Cancer - Joint Opinion from both the Endoscopic and Thoracic Oncology Sections of the German Society of Pneumology (DGP)]
Autor: W M, Brückl, J H, Ficker, M, Tiemann, C, Schumann, N, Reinmuth, D, Heigener, W, Schütte, R, Eberhardt, K, Darwiche, M, Wagner
Publikováno v: Pneumologie (Stuttgart, Germany). 72(9)
Performing rebiopsies for primary lung cancer and/or their metastases is becoming more and more prominent in daily practice, as the therapeutical spectrum increases and some newer strategies are dependent on immunohistochemical and/or molecular facto
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e4c7fe371062a8485b0a64bebf6ae5fc
https://pubmed.ncbi.nlm.nih.gov/30071539
Zobrazit plný text záznamu
9
[Liquid Biopsy: Detection of Molecular Markers for Treatment Decisions in Lung Cancer]
Autor: W M, Brückl, R M, Wirtz, T, Bertsch, J H, Ficker, A, Jung
Publikováno v: Pneumologie (Stuttgart, Germany). 71(3)
Personalized, individualized, targeted therapy has successfully found entrance in the palliative treatment of lung cancer as they enable a personalized and individualized strategy going ahead with biomarker testing. Due to the crescending amount of p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e6184b1ea1126699fab423f3ebf385f9
https://pubmed.ncbi.nlm.nih.gov/28196386
Zobrazit plný text záznamu
10
[Haemoptysis : Intensive care management of pulmonary hemorrhage]
Autor: J H, Ficker, W M, Brückl, J, Suc, A, Geise
Publikováno v: Der Internist. 58(3)
There is a wide spectrum of severities in patients with pulmonary bleeding with a range from mild haemoptysis to severe bleeding with an acute risk of asphyxiation. For the management of acute pulmonary haemorrhage, it is essential to identify the un
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5fd1a798a7fdc602bc3c0eaf4594a353
https://pubmed.ncbi.nlm.nih.gov/28138763
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje